These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2594307)

  • 1. AZT to cost less.
    Ohio Med; 1989 Dec; 85(12):932. PubMed ID: 2594307
    [No Abstract]   [Full Text] [Related]  

  • 2. The cost-effectiveness of treatment with lamivudine and zidovudine compared with zidovudine alone: a comparison of Markov model and trial data estimates.
    Mauskopf J; Lacey L; Kempel A; Simpson K
    Am J Manag Care; 1998 Jul; 4(7):1004-12. PubMed ID: 10181990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental cost-effectiveness of two zidovudine regimens to prevent perinatal HIV transmission in the United States.
    Pinkerton SD; Holtgrave DR; Layde PM
    Prev Med; 2000 Jan; 30(1):64-9. PubMed ID: 10642461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing HIV infection in infants and children by reducing perinatal HIV transmission: review of efficacy and preliminary cost evaluation. South Carolina Pediatric AIDS Advisory Committee.
    Johnson GM
    J S C Med Assoc; 1996 Mar; 92(3):121-7. PubMed ID: 8881607
    [No Abstract]   [Full Text] [Related]  

  • 6. Early treatment of HIV infection.
    Fessel WJ
    N Engl J Med; 1995 Dec; 333(26):1782; author reply 1783. PubMed ID: 7491153
    [No Abstract]   [Full Text] [Related]  

  • 7. [The costs of treating HIV-infected children in Abidjan, Ivory Coast, 1996-1997].
    Giraudon I; Leroy V; Msellati P; Elenga N; Ramon R; Welffens-Ekra C; Dabis F
    Sante; 1999; 9(5):277-81. PubMed ID: 10657769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nevirapine reduced mother-to-child transmission better than AZT--at 70 times less the cost.
    AIDS Treat News; 2003 Sep; (394):7. PubMed ID: 14669729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report on a 3-year follow-up zidovudine (AZT) treatment in a group of HIV-positive patients with congenital clotting disorders.
    Sartori MT; Mares M; Zerbinati P; Stocco D; Girolami A
    Haematologia (Budap); 1994; 26(1):17-27. PubMed ID: 7959371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of preventing HIV infection after sexual exposure.
    Lindbloom EJ; Stevermer JJ
    J Fam Pract; 1998 Oct; 47(4):251-2. PubMed ID: 9789505
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies say doctors are lax in assisting pregnant women.
    AIDS Policy Law; 1995 Jun; 10(12):4. PubMed ID: 11362637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. South African government abandons AZT pilot project.
    AIDS Alert; 1998 Dec; 13(12):suppl 1-2. PubMed ID: 11366066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the use of triple combination therapy in five countries: nevirapine, Zidovudine, and Didanosine.
    Biddle AK; Simpson KN
    Value Health; 2000; 3(3):186-201. PubMed ID: 16464183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3TC/AZT: just another combination.
    GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of zidovudine related mutations in the reverse transscriptase gene of HIV after switching therapy.
    Falkensammer B; El Attal R; Müllauer B; Sarcletti M; Parson W; Dierich MP; Stoiber H
    Eur J Med Res; 2002 Sep; 7(9):379-86. PubMed ID: 12435615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
    Mrus JM; Tsevat J
    Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zidovudine and lamivudine: results of phase III studies.
    Staszewski S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glaxo cuts HIV drug cost for developing world.
    Nature; 1998 Mar; 392(6672):118. PubMed ID: 9515951
    [No Abstract]   [Full Text] [Related]  

  • 19. [Resistance of human immunodeficiency virus (HIV) to zidovudine. Genotypic analysis in strains isolated from Chilean patients].
    Vial PA; Vial C; Abarca K; Noriega M; Jiménez G; Labarca J; Gasep J; Palacios O; Pérez C; Acuña G
    Rev Med Chil; 1998 Jan; 126(1):17-26. PubMed ID: 9629750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Open questions about HIV/AZT].
    Garattini S
    Riv Inferm; 1994; 13(2):104-6. PubMed ID: 7863189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.